Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Richard Francis
Pharma
Teva CEO celebrates progress in 'Pivot to Growth' plan
While Teva still has a "long way to go," the company is executing well on its Pivot to Growth strategy, CEO Richard Francis told Fierce.
Fraiser Kansteiner
May 8, 2024 3:02pm
Teva CEO Richard Francis earns $25.7M thanks to welcome package
Apr 17, 2024 1:00pm
Teva inks cancer biosimilar marketing pact with mAbxience
Apr 4, 2024 10:33am
Teva rolls along in 2nd year of 'Pivot to Growth' strategy
Jan 31, 2024 3:06pm
Teva reports revenue increase, says it will sell API business
Jan 31, 2024 11:11am
Teva's new 'pivot to growth' strategy seems to be paying off
Nov 13, 2023 11:20am